RTXMX
Price
$12.03
Change
+$0.16 (+1.35%)
Updated
Dec 20 closing price
SFCWX
Price
$69.39
Change
-$0.28 (-0.40%)
Updated
Dec 20 closing price
Ad is loading...

RTXMX vs SFCWX

Header iconRTXMX vs SFCWX Comparison
Open Charts RTXMX vs SFCWXBanner chart's image
Russell Inv Tax-Managed Real Assets M
Price$12.03
Change+$0.16 (+1.35%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World F3
Price$69.39
Change-$0.28 (-0.40%)
VolumeN/A
CapitalizationN/A
RTXMX vs SFCWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RTXMX vs. SFCWX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RTXMX is a StrongBuy and SFCWX is a Buy.

FUNDAMENTALS
Fundamentals
SFCWX has more cash in the bank: 73.6B vs. RTXMX (1.01B). RTXMX pays higher dividends than SFCWX: RTXMX (2.28) vs SFCWX (0.95). RTXMX was incepted earlier than SFCWX: RTXMX (6 years) vs SFCWX (8 years). RTXMX is a more actively managed with annual turnover of: 50.00 vs. SFCWX (29.00). RTXMX has a lower initial minimum investment than SFCWX: RTXMX (0) vs SFCWX (1000000). SFCWX annual gain was more profitable for investors over the last year : 4.67 vs. RTXMX (2.02). RTXMX return over 5 years is better than : 22.50 vs. SFCWX (14.96).
RTXMXSFCWXRTXMX / SFCWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years8 years-
Gain YTD1.2603.49436%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.01B73.6B1%
Annual Yield % from dividends2.280.95240%
Returns for 1 year2.024.6743%
Returns for 3 years-2.31-11.0121%
Returns for 5 years22.5014.96150%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMRC36.920.67
+1.85%
Digimarc Corp
DNLI21.45-0.04
-0.19%
Denali Therapeutics
AIM0.19N/A
-0.58%
AIM ImmunoTech
LYEL0.61-0.03
-4.41%
Lyell Immunopharma
XPO135.25-10.26
-7.05%
XPO